|
MAGED2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.17050000195229E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.68509999971023E-07 |
| Normal-vs-Stage2 |
6.882100E-02 |
| Normal-vs-Stage3 |
4.01160216156882E-11 |
| Normal-vs-Stage4 |
2.27460272839153E-11 |
| Stage1-vs-Stage2 |
3.654400E-02 |
| Stage1-vs-Stage3 |
1.110390E-02 |
| Stage1-vs-Stage4 |
9.965400E-04 |
| Stage2-vs-Stage3 |
2.016100E-03 |
| Stage2-vs-Stage4 |
3.355700E-04 |
| Stage3-vs-Stage4 |
3.312000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.23969999821227E-08 |
| Normal-vs-AfricanAmerican |
3.494100E-02 |
| Normal-vs-Asian |
6.91460000035171E-07 |
| Caucasian-vs-AfricanAmerican |
9.715800E-02 |
| Caucasian-vs-Asian |
9.921600E-01 |
| AfricanAmerican-vs-Asian |
1.501800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.30790000017068E-07 |
| Normal-vs-Female |
7.05890002006271E-09 |
| Male-vs-Female |
7.991200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.0100999999555E-07 |
| Normal-vs-Age(41-60Yrs) |
1.86930000034558E-07 |
| Normal-vs-Age(61-80Yrs) |
3.164399999811E-07 |
| Normal-vs-Age(81-100Yrs) |
9.103100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.916600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.044600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.843000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.891800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.199000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.457600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.68769999776242E-08 |
| Classical-VS-Follicular |
3.418300E-02 |
| Classical-VS-Other |
7.000600E-01 |
| Classical-VS-Normal |
1.71180000174687E-08 |
| Tall-VS-Follicular |
6.20079999569256E-08 |
| Tall-VS-Other |
2.210000E-01 |
| Tall-VS-Normal |
1.62914126633495E-12 |
| Follicular-VS-Other |
3.319200E-01 |
| Follicular-VS-Normal |
5.222800E-03 |
| Other-VS-Normal |
6.680400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.41180000004615E-06 |
| Normal-vs-N1 |
4.04565270173407E-13 |
| N0-vs-N1 |
1.62512999999365E-05 |
|
|
